Myriad Genetics | Actif À Court Terme

Created with Highcharts 10.1.0Chart context menu248M277M310M343M377M410M438M
2022Q32023Q32024Q3


Current Assets Changement Date
Agilent USD 4.11B 148M 2025-01
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
Bruker USD 2.06B 133.1M 2024-12
Danaher USD 9.5B 563M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Illumina USD 2.75B 373M 2024-12
J&J USD 55.89B 2.64B 2024-12
Mettler Toledo International USD 1.19B 4.33M 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Quest Diagnostics USD 2.39B 231M 2024-12
Quidel USD 1.22B 193.7M 2024-12
Repligen USD 1.13B 27.35M 2024-09
Revvity USD 2.35B 98.8M 2024-12
Standard Biotools USD 375.88M 77.73M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Veracyte USD 372.27M 15.41M 2024-12
Waters USD 1.67B 21.39M 2024-12



Myriad Genetics Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.